Suppression of har-1/CHCHD10 phenotypes for ALS-FTD therapy discovery

2025/04/10 by Audrey Labarre, Ericka Guitard, Gilles Tossing +1
Biochemistry, Genetics and Molecular Biology · Medicine · #Amyotrophic Lateral Sclerosis Research #Heat shock proteins research #Ubiquitin and proteasome pathways

paper · doi:10.17912/micropub.biology.001598

openalex publication_date 2025/04/10 · openalex created_date 2025/06/03 · openalex updated_date 2026/07/28

Abstract

mutants are suitable for modifier screens and could be adapted for high-throughput drug screening and microbiome studies to aid in discovering therapies for ALS-FTD.

Related

• har-1/CHCHD10 mutations induce neurodegeneration and mitochondrial fragmentation in Caenorhabditis elegans
• Advances in motor neurone disease
• Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD
• Design considerations for C9orf72 disease prevention trials
• Improvements of Paraquat Treatment in Liquid Media for Behavior and Neurodegenerative Tests